BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34530705)

  • 1. Neuroinflammation in Alzheimer's Disease: Focus on NLRP1 and NLRP3 Inflammasomes.
    de Brito Toscano EC; Rocha NP; Lopes BNA; Suemoto CK; Teixeira AL
    Curr Protein Pept Sci; 2021; 22(8):584-598. PubMed ID: 34530705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRP1 Inflammasome Activation in the Hippocampal Formation in Alzheimer's Disease: Correlation with Neuropathological Changes and Unbiasedly Estimated Neuronal Loss.
    Španić E; Langer Horvat L; Ilić K; Hof PR; Šimić G
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease.
    Zhang Y; Zhao Y; Zhang J; Yang G
    Neurochem Res; 2020 Nov; 45(11):2560-2572. PubMed ID: 32929691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.
    Stancu IC; Cremers N; Vanrusselt H; Couturier J; Vanoosthuyse A; Kessels S; Lodder C; Brône B; Huaux F; Octave JN; Terwel D; Dewachter I
    Acta Neuropathol; 2019 Apr; 137(4):599-617. PubMed ID: 30721409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease.
    Van Zeller M; Dias D; Sebastião AM; Valente CA
    J Alzheimers Dis; 2021; 83(3):939-961. PubMed ID: 34366341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.
    Li Y; Chen X; Zhou M; Feng S; Peng X; Wang Y
    J Alzheimers Dis; 2024; 97(1):75-88. PubMed ID: 38043010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
    Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A
    J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting NLRP3-Mediated Neuroinflammation in Alzheimer's Disease Treatment.
    Barczuk J; Siwecka N; Lusa W; Rozpędek-Kamińska W; Kucharska E; Majsterek I
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons.
    Moonen S; Koper MJ; Van Schoor E; Schaeverbeke JM; Vandenberghe R; von Arnim CAF; Tousseyn T; De Strooper B; Thal DR
    Acta Neuropathol; 2023 Feb; 145(2):175-195. PubMed ID: 36481964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 inflammasome activation drives tau pathology.
    Ising C; Venegas C; Zhang S; Scheiblich H; Schmidt SV; Vieira-Saecker A; Schwartz S; Albasset S; McManus RM; Tejera D; Griep A; Santarelli F; Brosseron F; Opitz S; Stunden J; Merten M; Kayed R; Golenbock DT; Blum D; Latz E; Buée L; Heneka MT
    Nature; 2019 Nov; 575(7784):669-673. PubMed ID: 31748742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.
    Yang J; Wise L; Fukuchi KI
    Front Immunol; 2020; 11():724. PubMed ID: 32391019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioredoxin-Interacting Protein (TXNIP) Associated NLRP3 Inflammasome Activation in Human Alzheimer's Disease Brain.
    Li L; Ismael S; Nasoohi S; Sakata K; Liao FF; McDonald MP; Ishrat T
    J Alzheimers Dis; 2019; 68(1):255-265. PubMed ID: 30741672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.
    Kuwar R; Rolfe A; Di L; Blevins H; Xu Y; Sun X; Bloom GS; Zhang S; Sun D
    J Alzheimers Dis; 2021; 82(4):1769-1783. PubMed ID: 34219728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis.
    de Dios C; Abadin X; Roca-Agujetas V; Jimenez-Martinez M; Morales A; Trullas R; Mari M; Colell A
    Transl Neurodegener; 2023 Mar; 12(1):10. PubMed ID: 36895045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of NLRP1, NLRP3, and AIM2 Inflammasomes in Psoriasis: Review.
    Ciążyńska M; Olejniczak-Staruch I; Sobolewska-Sztychny D; Narbutt J; Skibińska M; Lesiak A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis.
    Wang CY; Xu Y; Wang X; Guo C; Wang T; Wang ZY
    Antioxid Redox Signal; 2019 Apr; 30(11):1411-1431. PubMed ID: 29634349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia.
    Lučiūnaitė A; McManus RM; Jankunec M; Rácz I; Dansokho C; Dalgėdienė I; Schwartz S; Brosseron F; Heneka MT
    J Neurochem; 2020 Dec; 155(6):650-661. PubMed ID: 31872431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease.
    Saresella M; La Rosa F; Piancone F; Zoppis M; Marventano I; Calabrese E; Rainone V; Nemni R; Mancuso R; Clerici M
    Mol Neurodegener; 2016 Mar; 11():23. PubMed ID: 26939933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP3 and NLRP1 inflammasomes are up-regulated in patients with mesial temporal lobe epilepsy and may contribute to overexpression of caspase-1 and IL-β in sclerotic hippocampi.
    Cristina de Brito Toscano E; Leandro Marciano Vieira É; Boni Rocha Dias B; Vidigal Caliari M; Paula Gonçalves A; Varela Giannetti A; Maurício Siqueira J; Kimie Suemoto C; Elaine Paraizo Leite R; Nitrini R; Alvarenga Rachid M; Lúcio Teixeira A
    Brain Res; 2021 Feb; 1752():147230. PubMed ID: 33385378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.